CAREER DEVELOPMENT COMPONENT OF THE UCLA-ICMIC. F.I. The UCLA-ICMIC Career Development Component has been, and will continue to be, a flexible program. Our goal is to train outstanding candidates who have an interest in the interdisciplinary interface of basic cancer research and/or clinical-translational studies with molecular imaging applications. At the end of their ICMIC support, we hope their training will contribute to careers that increase cancer discovery research or improve diagnosis, prediction of response to therapy and/or monitoring of therapy. We are as flexible as possible with regard to the spectrum of trainees that we will recruit and support. However, we make - as a condition of support from Career Development resources - a provision that recipients participate in didactic instruction either in Cancer Biology or in principles of Biological Imaging (or both!) if the review committee is of the opinion that the candidate has a deficiency that will not be corrected by laboratory participation alone. Our Internal Review Board, made up of our Research Component P.l.s (Drs. Hong Wu, Caius Radu, Antoni Ribas), Drs. Herschman and Phelps, and Drs. Owen Witte and Jonathan Braun review applications and select trainees. We will also require, as a condition of support, that individual trainees participate in portions (tailored to the individual) of a """"""""curriculum"""""""" that includes specific courses, individual laboratory research group meetings, participation in Crump Institute for Molecular Imaging, Jonsson Comprehensive Cancer Center and Institute of Molecular Medicine internal seminars, and UCLA-ICMIC weekly research meetings. We will also request of trainees and their mentors that trainees receive some practical experience in all the imaging modalities available in our Specialized Resources. Our goal, in addition to a successful research project, will be that - at the conclusion of their support period - the trainees will be familiar with the fundamental principles of biological imaging and cancer biology, and expert in one or more areas of imaging and cancer research. While we will not expect trainees to have mastered radiosynthetic chemistry, mathematical reconstructions of tomographic images and all the other technologies required for their research in this interdisciplinary program, we will expect a working knowledge of all these areas and expertise in their areas of concentration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA086306-14
Application #
8541720
Study Section
Special Emphasis Panel (ZCA1-SRLB-9)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
14
Fiscal Year
2013
Total Cost
$143,062
Indirect Cost
$58,327
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kim, Woosuk; Le, Thuc M; Wei, Liu et al. (2016) [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. Proc Natl Acad Sci U S A 113:4027-32
Faltermeier, Claire M; Drake, Justin M; Clark, Peter M et al. (2016) Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A 113:E172-81
Kirkby, Nicholas S; Chan, Melissa V; Zaiss, Anne K et al. (2016) Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways. Proc Natl Acad Sci U S A 113:434-9
Tavaré, Richard; Escuin-Ordinas, Helena; Mok, Stephen et al. (2016) An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. Cancer Res 76:73-82
Atefi, Mohammad; Titz, Bjoern; Tsoi, Jennifer et al. (2016) CRAF R391W is a melanoma driver oncogene. Sci Rep 6:27454
Clark, Peter M; Mai, Wilson X; Cloughesy, Timothy F et al. (2016) Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma. Curr Neurol Neurosci Rep 16:17
Zaiss, Anne K; Foley, Erin M; Lawrence, Roger et al. (2016) Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo. J Virol 90:412-20
Barrio, Martin; Czernin, Johannes; Yeh, Michael W et al. (2016) The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Nucl Med Commun 37:1290-1296
Mok, Stephen; Tsoi, Jennifer; Koya, Richard C et al. (2015) Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition. BMC Cancer 15:356
Evdokimov, Nikolai M; Clark, Peter M; Flores, Graciela et al. (2015) Development of 2-Deoxy-2-[(18)F]fluororibose for Positron Emission Tomography Imaging Liver Function in Vivo. J Med Chem 58:5538-47

Showing the most recent 10 out of 216 publications